Progress regarding the context-of-use of tau as biomarker of Alzheimer’s disease and other neurodegenerative diseases-Reference-Cited by-同舟云学术

Progress regarding the context-of-use of tau as biomarker of Alzheimer’s disease and other neurodegenerative diseases

Published:2021-01-02 Issue:1 Volume:18 Page:27-48
ISSN:1478-9450
Container-title:Expert Review of Proteomics
language:en
Short-container-title:Expert Review of Proteomics

Author:

Campese Nicole¹,Palermo Giovanni¹,Del Gamba Claudia¹,Beatino Maria Francesca¹,Galgani Alessandro¹,Belli Elisabetta¹,Del Prete Eleonora¹,Della Vecchia Alessandra¹,Vergallo Andrea²,Siciliano Gabriele¹,Ceravolo Roberto¹,Hampel Harald²,Baldacci Filippo¹²^ORCID

Affiliation:

1. Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

2. GRC N° 21, Alzheimer Precision Medicine (APM), AP-HP, Pitié-Salpêtrière Hospital, Boulevard De L’hôpital, Sorbonne University, Paris, France

Publisher

Informa UK Limited

Subject

Molecular Biology,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/14789450.2021.1886929

Reference211 articles.

1. Tau pathology and neurodegeneration

2. Four-repeat tauopathies

3. New classification of tauopathies

4. Propagation of Tau Aggregates and Neurodegeneration

5. De L-RS, Moretto E, Schiavo G. Knockin’ on heaven’ s door: molecular mechanisms of neuronal tau uptake. J Neurochem. 2020;1–26.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. P-tau217 as a Reliable Blood-Based Marker of Alzheimer’s Disease;Biomedicines;2024-08-13

2. The role of brain noradrenaline in Alzheimer's disease: Implications for a precision medicine-oriented approach;Comprehensive Precision Medicine;2024

3. Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets;Biomolecules;2022-11-11

4. A Novel Deep Learning Radiomics Model to Discriminate AD, MCI and NC: An Exploratory Study Based on Tau PET Scans from ADNI;Brain Sciences;2022-08-12

5. A new generation of AD biomarkers: 2019 to 2021;Ageing Research Reviews;2022-08